🍽️ scopolamine hydrochloride,(prescription) [Can cause cognitive issues]

AI Engines For more Details: PerplexityKagi LabsYou

  1. Gastrointestinal Disorders: Scopolamine hydrochloride is used to relieve symptoms of gastrointestinal disorders such as irritable bowel syndrome (IBS), diverticulitis, and gastrointestinal spasms by reducing smooth muscle contractions and secretions in the digestive tract.

  2. Motion Sickness: It is commonly prescribed to prevent and treat motion sickness, including nausea, vomiting, and dizziness associated with travel by sea, air, or land.

  3. Preoperative Medication: Scopolamine hydrochloride is sometimes given before surgery to reduce saliva and other secretions in the respiratory tract, which can help prevent aspiration pneumonia during anesthesia.

  4. Antispasmodic: It acts as an antispasmodic agent, relieving muscle spasms and cramps in conditions such as renal colic, biliary colic, and other visceral pain syndromes.

  5. Ophthalmic Uses: Scopolamine hydrochloride is used in ophthalmology to dilate the pupil (mydriasis) and relax the ciliary muscle (cycloplegia) for diagnostic and therapeutic procedures.

  6. Parkinson's Disease: In some cases, it may be used as an adjunctive treatment for Parkinson's disease to help manage symptoms such as tremors and muscle stiffness.

  7. Side Effects: Common side effects of scopolamine hydrochloride include dry mouth, blurred vision, urinary retention, constipation, drowsiness, confusion, and increased heart rate. These effects are due to its anticholinergic properties and may vary in severity depending on the dosage and individual susceptibility.

  8. Contraindications: Scopolamine hydrochloride is contraindicated in individuals with narrow-angle glaucoma, urinary retention, severe ulcerative colitis, myasthenia gravis, and hypersensitivity to anticholinergic medications.

  9. Drug Interactions: It may interact with other medications, including antidepressants, antihistamines, antipsychotics, and certain antibiotics, leading to enhanced anticholinergic effects or other adverse reactions. Patients should inform their healthcare providers about all medications they are taking before using scopolamine hydrochloride.

  10. Transdermal Patch: Scopolamine hydrochloride is also available as a transdermal patch for the prevention of motion sickness. The patch delivers a controlled dose of medication through the skin, providing continuous relief over several days.

  11. Overdose: In cases of overdose or excessive use, scopolamine hydrochloride can cause severe anticholinergic toxicity, leading to symptoms such as delirium, hallucinations, seizures, and coma. Prompt medical attention is necessary in such cases.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of scopolamine hydrochloride,(prescription) [Can cause cognitive issues] On Probiotics

Rank Probiotic Impact
species Lacticaseibacillus paracasei Reduces

Bacteria Impacted by scopolamine hydrochloride,(prescription) [Can cause cognitive issues]

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Mediterraneibacter genus Decreases 👪 Source Study
Thomasclavelia genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
[Ruminococcus] gnavus species Decreases 📓 Source Study
Thomasclavelia ramosa species Decreases 📓 Source Study
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Streptococcus parasanguinis species Decreases 📓 Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Parvibacter caecicola species Decreases ⚗️ Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of scopolamine hydrochloride,(prescription) [Can cause cognitive issues] on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.1 0.1
Allergic Rhinitis (Hay Fever) 0.6 0.6
Alzheimer's disease 0.2 0.2
Ankylosing spondylitis 0.1 0.7 -6
Antiphospholipid syndrome (APS) 0.1 0.1
Atherosclerosis 0.1 0.1
Atrial fibrillation 0.1 0.1
Autism 0.8 0.1 7
Barrett esophagus cancer 0.1 0.1 0
Biofilm 0.9 0.9
Cancer (General) 0.2 -0.2
Carcinoma 0.1 0.1
Celiac Disease 0.1 0.1
Cerebral Palsy 0.1 0.1
Chronic Fatigue Syndrome 1 0.1 9
Chronic Kidney Disease 0.6 0.6
Chronic Obstructive Pulmonary Disease (COPD) 0.5 0.5
Chronic Urticaria (Hives) 0.1 0.1
Coagulation / Micro clot triggering bacteria 0.1 0.1 0
Colorectal Cancer 0.4 0.4
Coronary artery disease 0.6 0.6
COVID-19 0.5 0.6 -0.2
Crohn's Disease 0.8 0.1 7
deep vein thrombosis 0.1 -0.1
Depression 0.8 0.3 1.67
Dermatomyositis 0.1 0.1
Eczema 0.6 0.3 1
Endometriosis 0.1 0.1
Eosinophilic Esophagitis 0.1 0.1
Epilepsy 0.1 0.1
Fibromyalgia 0.4 0.4
gallstone disease (gsd) 0.1 -0.1
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.1 0.1 0
Generalized anxiety disorder 0.7 0.7
Glioblastoma 0.1 -0.1
Halitosis 0.1 0.1 0
Hidradenitis Suppurativa 0.1 0.1
hypertension (High Blood Pressure 0.1 0.1 0
IgA nephropathy (IgAN) 0.6 -0.6
Inflammatory Bowel Disease 1.3 1.3
Insomnia 0.1 0.1
Liver Cirrhosis 0.1 0.1 0
Long COVID 1.1 0.1 10
Mast Cell Issues / mastitis 0.1 0.1
ME/CFS with IBS 0.1 0.1
ME/CFS without IBS 0.8 0.8
Metabolic Syndrome 0.8 0.1 7
Mood Disorders 0.8 0.3 1.67
multiple chemical sensitivity [MCS] 0.3 0.3
Multiple Sclerosis 0.5 0.1 4
Multiple system atrophy (MSA) 0.1 0.1
Neuropathy (all types) 0.1 0.1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.1 0.1
Obesity 0.7 0.5 0.4
obsessive-compulsive disorder 0.1 0.6 -5
Osteoarthritis 1.1 1.1
pancreatic cancer 0.1 0.1
Parkinson's Disease 0.1 0.1 0
Psoriasis 0.1 0.1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.8 0.1 7
Sjögren syndrome 0.1 0.1
Sleep Apnea 0.1 0.1
Small Intestinal Bacterial Overgrowth (SIBO) 0.1 0.1
Stress / posttraumatic stress disorder 0.1 0.1
Systemic Lupus Erythematosus 0.8 0.8
Type 1 Diabetes 0.1 -0.1
Type 2 Diabetes 0.8 0.1 7
Ulcerative colitis 0.2 0.2
Unhealthy Ageing 0.9 0.9

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results. < p > Explanations / Info / Descriptions are influenced by < a href = "/home/sources" target = "_blank" > Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction. < p style = "font-size" .4em"> Copyright 2016 - 2024 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA < br /> Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. < br />< em > Caveat emptor: Analysis and suggestions are based on modelling(and thus < i > infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions / Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant or equivalent EU laws. [44.213.60 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [44.213.60 ]